A nationwide study of breast reconstruction after mastectomy in patients with breast cancer receiving postmastectomy radiotherapy: comparison of complications according to radiotherapy fractionation and reconstruction procedures

Background We examined the patterns of breast reconstruction postmastectomy in breast cancer patients undergoing postmastectomy radiotherapy (PMRT) and compared complications based on radiotherapy fractionation and reconstruction procedures.

Methods Using National Health Insurance Service (NHIS) data (2015–2020), we analysed 4669 breast cancer patients with PMRT and reconstruction.

Using propensity matching, cohorts for hypofractionated fractionation (HF) and conventional fractionation (CF) were created, adjusting for relevant factors and identifying grade ≥3 complications.

Result Of 4,669 patients, 30.6% underwent HF and 69.4% CF.

The use of HF has increased from 19.4% in 2015 to 41.0% in 2020.

Immediate autologous (32.9%) and delayed two-stage implant reconstruction (33.9%) were common.

Complication rates for immediate ( N  = 1286) and delayed two-stage ( N  = 784) reconstruction were similar between HF and CF groups (5.1% vs. 5.4%, P  = 0.803, and 10.5% vs. 10.7%, P  = 0.856, respectively) with median follow-ups of 2.5 and 2.6 years.

HF showed no increased risk of complications across reconstruction methods.

Conclusion A nationwide cohort study revealed no significant difference in complication rates between the HF and CF groups, indicating HF for reconstructed breasts is comparable to CF. However, consultation regarding the fractionation for reconstructed breast cancer patients may still be necessary.